Clinical Trial Update: Diamel in the Treatment of Type 2 Diabetic Patients Receiving Insulin Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Diamel in Type 2 diabetes patients receiving insulin therapy has completed, with Catalysis SL listed as the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Diamel

Snippet

Sponsor: Catalysis SL | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED